{"company":{"id":7994,"name":"Bristol Myers Squibb","domain":"bms.com","url":"https://alion.io/company/bms"},"section":"contracts","answer":"Bristol Myers Squibb has won 146 public contracts worth $878.7M on record.","figures":[{"label":"Contracts","value":"146"},{"label":"Value","value":"$878.7M"},{"label":"In 12 months","value":"$450.3M"}],"blocks":[{"key":"contracts","title":"Contracts","source":"public procurement portals and registers (EU TED, USAspending, World Bank, national e-procurement systems) - award notices and bid lists naming the company or its legal entities","rows":100},{"key":"buyers","title":"Biggest buyers","source":"","rows":10},{"key":"bids","title":"Tenders entered","source":"public procurement portals and registers (EU TED, USAspending, World Bank, national e-procurement systems) - award notices and bid lists naming the company or its legal entities","rows":4}],"contracts":[{"date":"2026-11-19","buyer":"Servizo Galego de Saúde. Área Sanitaria de Ferrol","country":"Spain","subject":"Suministro sucesivo de medicamentos de inmunoterapia oncológica para el Área Sanitaria de Ferrol","value_usd":"$435k","url":"https://ted.europa.eu/en/notice/-/detail/806759-2026"},{"date":"2026-11-17","buyer":"Consellería de Sanidade- SERGAS","country":"Spain","subject":"EN La-ASF1-26-028. La contratación, mediante Acuerdo Marco con varios empresarios, de él suministro sucesivo de los medicamentos de inmunoterapia oncológica para él Área Sanitario de Ferrol","value_usd":"$1.1M","url":"https://www.contratosdegalicia.gal/licitacion?N=829598"},{"date":"2026-11-12","buyer":"Hospital Universitario Príncipe de Asturias","country":"Spain","subject":"Namuscla 167 mg cápsulas duras, 100 cápsulas","value_usd":"$19k","url":"https://contratos-publicos.comunidad.madrid/contrato-publico/pnsp-hupa-3226-suministro-medicamentos-namuscla-167-mg-capsulas-duras-100-capsulas"},{"date":"2026-11-09","buyer":"Consellería de Sanidade- SERGAS","country":"Spain","subject":"EN La-ASP1-26-019. La contratación, mediante Acuerdo Marco con varios empresarios, de él suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios de él Servicio Gallego de Salud","value_usd":"$1.6M","url":"https://www.contratosdegalicia.gal/licitacion?N=829531"},{"date":"2026-11-06","buyer":"XUNTA DE GALICIA/CONSELLERIA DE SANIDADE/SERGAS/ÁREA SANITARIA DE PONTEVEDRA E O SALNÉS","country":"Spain","subject":"SUMINISTRO SUCESIVO DE MEDICAMENTOS DE INMUNOTERAPIA ONCOLÓGICA PARA LOS CENTROS HOSPITALARIOS EN EL ÁREA SANITARIA DE PONTEVEDRA E O SALNÉS.","value_usd":"$1.4M","url":"https://ted.europa.eu/en/notice/-/detail/798930-2026"},{"date":"2026-11-06","buyer":"XUNTA DE GALICIA/CONSELLERIA DE SANIDADE/SERGAS/ÁREA SANITARIA DE PONTEVEDRA E O SALNÉS","country":"Spain","subject":"SUMINISTRO SUCESIVO DE MEDICAMENTOS DE INMUNOTERAPIA ONCOLÓGICA PARA LOS CENTROS HOSPITALARIOS EN EL ÁREA SANITARIA DE PONTEVEDRA E O SALNÉS.","value_usd":"$1.2M","url":"https://ted.europa.eu/en/notice/-/detail/798930-2026"},{"date":"2026-11-05","buyer":"Pohjois-Pohjanmaan hyvinvointialue","country":"Finland","subject":"Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2027 + optiovuosi 2028 Pohjois-Pohjanmaan hyvinvointialueelle","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/770684-2026"},{"date":"2026-11-04","buyer":"OSAKIDETZA - Servicio Vasco de Salud - Organización Central","country":"Spain","subject":"Suministros de Nivolumab (DOE), Ipilimumab (DOE), Fedratinib (DOE), Luspatercept (DOE), Azacitidina (DOE) y Abatacept (DOE)","value_usd":"$51.9M","url":"https://ted.europa.eu/en/notice/-/detail/765088-2026"},{"date":"2026-10-30","buyer":"Consellería de Sanidade- SERGAS","country":"Spain","subject":"EN La-ASC1-26-054. Él suministro sucesivo de él medicamento de terapia avanzada Lisocabtagén maraleucel, en tratamiento individual por paciente.","value_usd":"not stated","url":"https://www.contratosdegalicia.gal/licitacion?N=829473"},{"date":"2026-10-29","buyer":"Servicio Cántabro de Salud","country":"Spain","subject":"Suministro de medicamentos sin competencia para el Hospital Comarcal de Laredo (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod).","value_usd":"$11k","url":"https://contrataciondelestado.es/wps/poc?uri=deeplink:detalle_licitacion&idEvl=76oG6%2FO0GqR%2BF6L2uCfUWg%3D%3D"},{"date":"2026-10-29","buyer":"Servicio Cántabro de Salud","country":"Spain","subject":"Suministro de medicamentos sin competencia para el Hospital Comarcal de Laredo (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod).","value_usd":"$6.7k","url":"https://contrataciondelestado.es/wps/poc?uri=deeplink:detalle_licitacion&idEvl=Aw5cb%2BNbrmX%2Fa9DgO%2BoYKQ%3D%3D"},{"date":"2026-10-28","buyer":"Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud","country":"Spain","subject":"Suministro sucesivo del medicamento \"Lisocabtagen Maraleucel\"","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/765443-2026"},{"date":"2026-10-27","buyer":"Servicio Andaluz de Salud. Hospital Universitario Puerta del Mar.","country":"Spain","subject":"EXPEDIENTE 2204/2025, Nº SIGLO 578/2025, CCA +6.I+E9Q8J CONTR BAM 2026 208773, CON LA EMPRESA BRISTOL MYERS SQUIBB, S.A","value_usd":"$1.4M","url":"https://ted.europa.eu/en/notice/-/detail/742839-2026"},{"date":"2026-10-20","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAEN CBAM (1ª PRORROGA) BRISTOL-MYERS SQUIBB, S.A. AM 376/2025","value_usd":"$1.1M","url":"https://ted.europa.eu/en/notice/-/detail/738966-2026"},{"date":"2026-10-07","buyer":"Servicio Gallego de Salud. Área Sanitaria de Santiago de Compostela y Barbanza","country":"Spain","subject":"Suministro sucesivo de los medicamentos de inmunoterapia oncológica para el Área de Santiago de Compostela y Barbanza","value_usd":"$1.1M","url":"https://ted.europa.eu/en/notice/-/detail/690950-2026"},{"date":"2026-10-05","buyer":"Regione Autonoma della Sardegna","country":"Italy","subject":"Medicinali 26","value_usd":"$10M","url":"https://ted.europa.eu/en/notice/-/detail/770692-2026"},{"date":"2026-10-05","buyer":"SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO REGIONAL DE MÁLAGA","country":"Spain","subject":"CBAM 578/2025 BRISTOL/01","value_usd":"$4M","url":"https://ted.europa.eu/en/notice/-/detail/684304-2026"},{"date":"2026-10-01","buyer":"Consellería de Sanidade- SERGAS","country":"Spain","subject":"EN La-ASGO1-26-024. Suministro sucesivo de los medicamentos de inmunoterapia oncológica para él Área Sanitario de Ourense, Verín y O Barco de Valdeorras","value_usd":"$2M","url":"https://www.contratosdegalicia.gal/licitacion?N=829266"},{"date":"2026-09-29","buyer":"Servicio Gallego de Salud - Área Sanitaria de Lugo, A Mariña y Monforte de Lemos","country":"Spain","subject":"SUMINISTRO SUCESIVO DE LOS MEDICAMENTOS DE INMUNOTERAPIA ONCOLÓGICA PARA LOS CENTROS HOSPITALARIOS DEL ÁREA SANITARIA DE LUGO, A MARIÑA Y MONFORTE DE LEMOS.","value_usd":"$2.1M","url":"https://ted.europa.eu/en/notice/-/detail/667813-2026"},{"date":"2026-09-29","buyer":"Servicio Andaluz de Salud. Central Provincial de Compras de Almería","country":"Spain","subject":"ALMERIA 2º CBAM CONTR 2026 0000202933_2","value_usd":"$388k","url":"https://ted.europa.eu/en/notice/-/detail/676242-2026"},{"date":"2026-09-25","buyer":"Servicio Andaluz de Salud. Central Provincial de Compras de Almería","country":"Spain","subject":"ALMERIA 2º CBAM CONTR 2026 0000331090","value_usd":"$386k","url":"https://ted.europa.eu/en/notice/-/detail/667799-2026"},{"date":"2026-09-11","buyer":"Área Sanitaria da Coruña e Cee - Servicio Gallego de Salud","country":"Spain","subject":"Suministro sucesivo del medicamento \"Lisocabtagen Maraleucel\"","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/696586-2026"},{"date":"2026-09-08","buyer":"Pohjois-Pohjanmaan hyvinvointialue","country":"Finland","subject":"Lääkevalmisteet ja niihin rinnastettavat tuotteet hankintakaudelle 1.1.2026-31.12.2027","value_usd":"$1","url":"https://ted.europa.eu/en/notice/-/detail/618924-2026"},{"date":"2026-09-04","buyer":"Consorci Sanitari de l'Anoia","country":"Spain","subject":"Contrato para el suministro de medicamentos oncológicos para el Consorci Sanitari de l'Anoia","value_usd":"$126k","url":"https://ted.europa.eu/en/notice/-/detail/611629-2026"},{"date":"2026-08-24","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAEN CBAM ASTELLAS PHARMA, S.A. AM 8/2025","value_usd":"$1.2M","url":"https://ted.europa.eu/en/notice/-/detail/611452-2026"},{"date":"2026-08-21","buyer":"Servicio Cántabro de Salud","country":"Spain","subject":"Acuerdo Marco para el suministro de medicamentos sin competencia para los hospitales del Servicio Cántabro de Salud (Principios activos Luspatercept, Mavacamten, Fedratinib, Belatacept, Abatacept, Deucravacitinib, Ipilimumab, Ozanimod).","value_usd":"$10.1M","url":"https://ted.europa.eu/en/notice/-/detail/657724-2026"},{"date":"2026-08-07","buyer":"Servicio Cántabro de Salud","country":"Spain","subject":"Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.","value_usd":"$18.1M","url":"https://ted.europa.eu/en/notice/-/detail/662282-2026"},{"date":"2026-07-20","buyer":"ICS - Hospital Universitari Vall Hebron","country":"Spain","subject":"Suministro de medicamentos para el Hospital Universitari Vall d'Hebrón","value_usd":"$670k","url":"https://ted.europa.eu/en/notice/-/detail/498308-2026"},{"date":"2026-07-18","buyer":"Servicio Gallego de Salud","country":"Spain","subject":"La contratación, mediante Acuerdo Marco con un único empresario, del suministro sucesivo del medicamento de terapia avanzada Lisocabtagén maraleucel, en tratamiento individual por paciente.","value_usd":"$22.7M","url":"https://ted.europa.eu/en/notice/-/detail/600560-2026"},{"date":"2026-07-01","buyer":"HOSPITAL CLINICO SAN CARLOS","country":"Spain","subject":"Suministro MAVACAMTEN ORAL (CAMZYOS), de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid","value_usd":"$219k","url":"https://ted.europa.eu/en/notice/-/detail/451656-2026"},{"date":"2026-06-30","buyer":"CONSORCI HOSPITAL CLÍNIC DE BARCELONA (HCB)","country":"Spain","subject":"2026-90 Suministro del medicamento Lisocabtágeno maraleucel (Breyanzi®) para el Hospital Clínic de Barcelona (HCB).","value_usd":"$2.8M","url":"https://ted.europa.eu/en/notice/-/detail/603105-2026"},{"date":"2026-06-29","buyer":"Servicio Madrileño de Salud - Hospital Universitario La Paz","country":"Spain","subject":"ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: MAVACAMTEN (CAMZYOS), AZTREONAM (AZACTAM).","value_usd":"$208k","url":"https://ted.europa.eu/en/notice/-/detail/443842-2026"},{"date":"2026-06-25","buyer":"OSAKIDETZA - Servicio Vasco de Salud - Organización Central","country":"Spain","subject":"Suministro de Lisocabtagen maraleucel (DOE)","value_usd":"$71M","url":"https://ted.europa.eu/en/notice/-/detail/431930-2026"},{"date":"2026-06-15","buyer":"Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez","country":"Spain","subject":"HUELVA 1º CBAM AM 2204/2025 (Nº SIGLO 578/2025 ;CCA:+6.I+E9Q8J)","value_usd":"$461k","url":"https://ted.europa.eu/en/notice/-/detail/503684-2026"},{"date":"2026-06-09","buyer":"Consorci de Salut i d'Atenció Social de Catalunya","country":"Spain","subject":"Acuerdo Marco del Suministro de MEDICAMENTOS ONCOLÓGICOS","value_usd":"$7.3M","url":"https://ted.europa.eu/en/notice/-/detail/393236-2026"},{"date":"2026-06-04","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAEN CBAM BRISTOL-MYERS SQUIBB, S.A. AM 376/2025","value_usd":"$549k","url":"https://ted.europa.eu/en/notice/-/detail/609984-2026"},{"date":"2026-06-04","buyer":"Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil","country":"Spain","subject":"Suministro de los productos farmacéuticos Mavacamten, Inclisirán y Aripiprazol para el Complejo Hospitalario Universitario Insular-Materno Infantil de Gran Canaria","value_usd":"$137k","url":"https://ted.europa.eu/en/notice/-/detail/476683-2026"},{"date":"2026-06-01","buyer":"HOSPITAL CLINICO SAN CARLOS","country":"Spain","subject":"SUMINISTRO DE ENFORTUMAB VEDOTINA (PADCEV 20 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION)","value_usd":"$388k","url":"https://ted.europa.eu/en/notice/-/detail/373838-2026"},{"date":"2026-06-01","buyer":"Gerencia de Atención Sanitaria de Melilla - Instituto Nacional de Gestión Sanitaria","country":"Spain","subject":"Suministro de medicamentos exclusivos de la empresa Astellas Pharma, S.A. dispensados en el Hospital Universitario dependiente del INGESA para los pacientes de la Gerencia de Atención Sanitaria de Melilla.","value_usd":"$139k","url":"https://ted.europa.eu/en/notice/-/detail/566964-2026"},{"date":"2026-05-28","buyer":"Hospital Universitario Ramón y Cajal","country":"Spain","subject":"Adquisición del medicamento BREYANZI 1,1-70 x 10E6 Células/ML dispersión para perfusión (Lisocabtagen Maraleucel), para el Servicio de Farmacia del Hospital Universitario Ramón y Cajal.","value_usd":"$3.1M","url":"https://ted.europa.eu/en/notice/-/detail/431556-2026"},{"date":"2026-05-28","buyer":"SERVICIO ANDALUZ DE SALUD. HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES","country":"Spain","subject":"CONTR 2026 200899 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS","value_usd":"$1.6M","url":"https://ted.europa.eu/en/notice/-/detail/640175-2026"},{"date":"2026-05-26","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAEN CBAM BRISTOL-MYERS SQUIB, S.A. AM 1229/2024","value_usd":"$2.2M","url":"https://ted.europa.eu/en/notice/-/detail/397089-2026"},{"date":"2026-05-08","buyer":"Servicio Gallego de Salud","country":"Spain","subject":"La contratación, mediante Acuerdo Marco con varios empresarios, del suministro sucesivo de los medicamentos de inmunoterapia oncológica para los centros hospitalarios del Servicio Gallego de Salud","value_usd":"$13.4M","url":"https://ted.europa.eu/en/notice/-/detail/435978-2026"},{"date":"2026-05-07","buyer":"Servicio de Salud - Servicios Centrales","country":"Spain","subject":"d_sanitaria_acuerdo marco_ medicamentos exclusivos III","value_usd":"$12.2M","url":"https://ted.europa.eu/en/notice/-/detail/403479-2026"},{"date":"2026-05-05","buyer":"Servicio Madrileño de Salud - Hospital Universitario La Paz","country":"Spain","subject":"SUMINISTRO DEL MEDICAMENTO EXCLUSIVO IDECABTAGEN VICLEUCEL (ABECMA)","value_usd":"$699k","url":"https://ted.europa.eu/en/notice/-/detail/306542-2026"},{"date":"2026-04-23","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAÉN CBAM AM 1229/2024 BRISTOL-MYERS SQUIBB S.A.","value_usd":"$479k","url":"https://ted.europa.eu/en/notice/-/detail/285197-2026"},{"date":"2026-04-22","buyer":"Sansia Oy","country":"Finland","subject":"Lääkkeiden erillishankinnat Itä-Suomen yhteistyöalueelle, syksy 2025","value_usd":"$193k","url":"https://ted.europa.eu/en/notice/-/detail/275726-2026"},{"date":"2026-04-16","buyer":"Gerencia Regional de Salud de Castilla y León","country":"Spain","subject":"Suministro de diversos medicamentos exclusivos con destino a los centros sanitarios dependientes de la Gerencia Regional de Salud de Castilla y León","value_usd":"$5.8M","url":"https://ted.europa.eu/en/notice/-/detail/395471-2026"},{"date":"2026-04-15","buyer":"Servicio Andaluz de Salud. Servicios Centrales","country":"Spain","subject":"A.M suministros CONTR 2025 0000519166","value_usd":"$115.8M","url":"https://ted.europa.eu/en/notice/-/detail/359558-2026"},{"date":"2026-04-08","buyer":"Gerencia del Hospital Intermutual de Levante","country":"Spain","subject":"Acuerdo Marco de Medicamentos","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/308281-2026"},{"date":"2026-04-01","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 7.Contrato basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud.","value_usd":"$4.1M","url":"https://ted.europa.eu/en/notice/-/detail/223921-2026"},{"date":"2026-04-01","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 8.Contrato basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud.","value_usd":"$24k","url":"https://ted.europa.eu/en/notice/-/detail/225804-2026"},{"date":"2026-03-31","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 24.Contrato basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud.","value_usd":"$7M","url":"https://ted.europa.eu/en/notice/-/detail/219258-2026"},{"date":"2026-03-31","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 23.Contrato basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud.","value_usd":"$1.6M","url":"https://ted.europa.eu/en/notice/-/detail/221413-2026"},{"date":"2026-03-31","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 25.Contrato basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del servicio extremeño de salud.","value_usd":"$136k","url":"https://ted.europa.eu/en/notice/-/detail/222367-2026"},{"date":"2026-03-03","buyer":"PBMG eG","country":"Germany","subject":"Arzneimittelvergaben zum 01.01.2026 und 01.07.2026","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/465169-2026"},{"date":"2026-03-03","buyer":"PBMG eG","country":"Germany","subject":"Arzneimittelvergaben zum 01.01.2026 und 01.07.2026","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/465169-2026"},{"date":"2026-03-03","buyer":"PBMG eG","country":"Germany","subject":"Arzneimittelvergaben zum 01.01.2026 und 01.07.2026","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/465169-2026"},{"date":"2026-03-02","buyer":"PBMG eG","country":"Germany","subject":"Arzneimittelvergaben zum 01.01.2026 und 01.07.2026","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/465169-2026"},{"date":"2026-02-20","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"JAEN 5º CBAM AM 8/2025","value_usd":"$1.3M","url":"https://ted.europa.eu/en/notice/-/detail/190881-2026"},{"date":"2026-02-06","buyer":"Servicio Andaluz de Salud. Área Hospitalaria Virgen del Rocío.","country":"Spain","subject":"CBAM del AM CONTR 2024 / 1031923 (PNAMSP 133/2024 ) BRISTOL MYERS SQUIBB","value_usd":"$7M","url":"https://ted.europa.eu/en/notice/-/detail/87312-2026"},{"date":"2026-02-05","buyer":"OSAKIDETZA - Servicio Vasco de Salud - Organización Central","country":"Spain","subject":"Suministro de Belatacept (DOE)","value_usd":"$801k","url":"https://ted.europa.eu/en/notice/-/detail/85898-2026"},{"date":"2026-01-22","buyer":"Consorci Sanitari Integral","country":"Spain","subject":"Adjudicación del Contrato Específico del Medicamento MAVACAMTEN, derivado del Sistema Dinámico de Adquisición del Suministro de Medicamentos Exclusivos, para el Consorci Sanitari Integral","value_usd":"$363k","url":"https://ted.europa.eu/en/notice/-/detail/49183-2026"},{"date":"2026-01-07","buyer":"Servicio Gallego de Salud","country":"Spain","subject":"La contratación, mediante Acuerdo Marco, del suministro sucesivo de los medicamentos IDECABTAGÉN VICLEUCEL y CILTACABTAGÉN AUTOLEUCEL para los centros hospitalarios del Servicio Gallego de Salud","value_usd":"$54.8M","url":"https://ted.europa.eu/en/notice/-/detail/112351-2026"},{"date":"2025-12-23","buyer":"Hospital Universitario Ramón y Cajal","country":"Spain","subject":"Adquisición del fármaco Abecma 260-500 x 10e6 células dispersión para perfusión (Idecabtagen Vicleucel), con destino al Servicio de Farmacia, del Hospital Universitario Ramón y Cajal","value_usd":"$181k","url":"https://ted.europa.eu/en/notice/-/detail/54256-2026"},{"date":"2025-12-15","buyer":"Servicio Madrileño de Salud - Hospital Universitario La Paz","country":"Spain","subject":"ADQUISICIÓN DE MEDICAMENTOS EXCLUSIVOS: MAVACAMTEN (CAMZYOS), AZTREONAM (AZACTAM).","value_usd":"$209k","url":"https://ted.europa.eu/en/notice/-/detail/829656-2025"},{"date":"2025-12-10","buyer":"HOSPITAL CLINICO SAN CARLOS","country":"Spain","subject":"Suministro de LUSPATERCEPT (REBLOZYL) de distribución exclusiva con destino al Servicio de Farmacia del Hospital Clínico San Carlos de Madrid","value_usd":"$508k","url":"https://ted.europa.eu/en/notice/-/detail/819273-2025"},{"date":"2025-12-03","buyer":"Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote","country":"Spain","subject":"Suministro de medicamentos de uso humano tipo II (medicamentos exclusivos)","value_usd":"$697k","url":"https://ted.europa.eu/en/notice/-/detail/801427-2025"},{"date":"2025-12-03","buyer":"Teilnehmende Gesundheitseinrichtungen der EKK plus GmbH","country":"Germany","subject":"Opdivo 2026","value_usd":"$1.1k","url":"https://ted.europa.eu/en/notice/-/detail/805900-2025"},{"date":"2025-11-25","buyer":"Dirección General de Gestión Económica, Contratación e Infraestructuras de la Conselleria de Sanidad","country":"Spain","subject":"Suministro, respetuoso con el medio ambiente, de medicamentos de uso humano cuyos principios activos son mavacamten, fedratinib, abatacept, ipilimumb, nivolumab, luspatercept, cobicistat/atazanavir, deucravanacitinib y ozanimod, con destino a los centros del ámbito de la sanidad pública valenciana","value_usd":"not stated","url":"https://ted.europa.eu/en/notice/-/detail/868491-2025"},{"date":"2025-11-19","buyer":"Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez","country":"Spain","subject":"HUELVA 6º CBAM 995/20 AM 2207/20 BRISTOL MYERS SQUIBB S.A.","value_usd":"$1.1M","url":"https://ted.europa.eu/en/notice/-/detail/765858-2025"},{"date":"2025-11-18","buyer":"HUS-yhtymä","country":"Finland","subject":"CAR-T-soluterapiavalmisteet hankintakaudelle 1.1.2026 – 31.12.2027","value_usd":"$7.3M","url":"https://ted.europa.eu/en/notice/-/detail/763637-2025"},{"date":"2025-11-14","buyer":"CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL","country":"Spain","subject":"FÁRMACOS EXCLUSIVOS","value_usd":"$205k","url":"https://ted.europa.eu/en/notice/-/detail/44393-2026"},{"date":"2025-11-14","buyer":"CONSORCIO CORPORACIÓ SANITÀRIA PARC TAULÍ DE SABADELL","country":"Spain","subject":"FÁRMACOS EXCLUSIVOS","value_usd":"$162k","url":"https://ted.europa.eu/en/notice/-/detail/42722-2026"},{"date":"2025-11-11","buyer":"Ente Público Hospital Universitario de Fuenlabrada","country":"Spain","subject":"PNSP SUM 25-025","value_usd":"$289k","url":"https://ted.europa.eu/en/notice/-/detail/12476-2026"},{"date":"2025-10-29","buyer":"Servicio Madrileño de Salud - Hospital Universitario La Paz","country":"Spain","subject":"SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: LUSTANERCEPT (REBLOZYL), DEUCRAVACITINIB (SOTYKTU) Y TRIAMCINOLONA (TRIGON DEPOT).","value_usd":"$341k","url":"https://ted.europa.eu/en/notice/-/detail/713614-2025"},{"date":"2025-10-24","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Málaga","country":"Spain","subject":"CONTR 2025 0000413325","value_usd":"$13.3M","url":"https://ted.europa.eu/en/notice/-/detail/94644-2026"},{"date":"2025-10-09","buyer":"Servicio de Salud - Servicios Centrales","country":"Spain","subject":"acuerdo marco_medicamentos_dsanitaria exclusivos I","value_usd":"$25.6M","url":"https://ted.europa.eu/en/notice/-/detail/804330-2025"},{"date":"2025-10-07","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"Suministros ( CCA. +IA83G8)","value_usd":"$1.9M","url":"https://ted.europa.eu/en/notice/-/detail/829-2026"},{"date":"2025-10-07","buyer":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","country":"Spain","subject":"Suministros ( CCA. +IA83G8)","value_usd":"$1.9M","url":"https://ted.europa.eu/en/notice/-/detail/829-2026"},{"date":"2025-09-29","buyer":"HOSPITAL UNIVERSITARIO REINA SOFIA","country":"Spain","subject":"AM SUMINISTROS (CONTR 2025 0000292876)","value_usd":"$6.4M","url":"https://ted.europa.eu/en/notice/-/detail/634434-2025"},{"date":"2025-09-25","buyer":"Servicio Madrileño de Salud - Hospital Universitario La Paz","country":"Spain","subject":"SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ODEVIXIBAT (BILVAY), MECASERMINA (INCRELEX), TRIPTORELINA (DECAPEPTYL).","value_usd":"$140k","url":"https://ted.europa.eu/en/notice/-/detail/626912-2025"},{"date":"2025-09-24","buyer":"Hospital Universitario Jaén","country":"Spain","subject":"AM SUMINISTROS (CONTR 2025 0000300222)","value_usd":"$3.1M","url":"https://ted.europa.eu/en/notice/-/detail/623668-2025"},{"date":"2025-08-21","buyer":"HOSPITAL UNIVERSITARIO DE GETAFE","country":"Spain","subject":"PNSP 2024-3-12","value_usd":"$170k","url":"https://ted.europa.eu/en/notice/-/detail/545660-2025"},{"date":"2025-08-21","buyer":"HOSPITAL UNIVERSITARIO DE GETAFE","country":"Spain","subject":"PNSP 2024-3-12","value_usd":"$170k","url":"https://ted.europa.eu/en/notice/-/detail/545660-2025"},{"date":"2025-08-21","buyer":"HOSPITAL UNIVERSITARIO DE GETAFE","country":"Spain","subject":"PNSP 2024-3-12","value_usd":"$170k","url":"https://ted.europa.eu/en/notice/-/detail/545660-2025"},{"date":"2025-08-07","buyer":"Dirección General de Recursos Económicos del Servicio Canario de la Salud","country":"Spain","subject":"Suministro de Medicamentos de Uso Humano tipo II (Medicamentos Exclusivos) con destino al Servicio Canario de la Salud.","value_usd":"$10.1M","url":"https://ted.europa.eu/en/notice/-/detail/671664-2025"},{"date":"2025-07-29","buyer":"HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS","country":"Spain","subject":"PNSP HUPA 61/25","value_usd":"$150k","url":"https://ted.europa.eu/en/notice/-/detail/121425-2026"},{"date":"2025-07-16","buyer":"Servicio Murciano de Salud - Junta de Compras","country":"Spain","subject":"Suministro Medicamentos exclusivos con principios activos nivolumab, ipilimumab, abatacept, fedratinib, mavacamten, deucravacitinib y azacitidina en comprimidos","value_usd":"$16.7M","url":"https://ted.europa.eu/en/notice/-/detail/521997-2025"},{"date":"2025-07-04","buyer":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","country":"Italy","subject":"ARIA_2024_008.19 - Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la fornitura di farmaci e servizi connessi","value_usd":"$21M","url":"https://ted.europa.eu/en/notice/-/detail/855169-2025"},{"date":"2025-07-04","buyer":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","country":"Italy","subject":"ARIA_2024_008.19 - Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la fornitura di farmaci e servizi connessi","value_usd":"$21M","url":"https://ted.europa.eu/en/notice/-/detail/855169-2025"},{"date":"2025-06-27","buyer":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","country":"Italy","subject":"ARIA_2024_008.20 - Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la fornitura di farmaci e servizi connessi","value_usd":"$20.3M","url":"https://ted.europa.eu/en/notice/-/detail/859691-2025"},{"date":"2025-06-27","buyer":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","country":"Italy","subject":"ARIA_2024_008.20 - Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la fornitura di farmaci e servizi connessi","value_usd":"$20.3M","url":"https://ted.europa.eu/en/notice/-/detail/859691-2025"},{"date":"2025-06-27","buyer":"Consorci Sanitari de l'Anoia","country":"Spain","subject":"CONTRATACIÓN BASADA DEL ACUERDO MARCO DEL SUMINISTRO DE MEDICAMENTOS INMUNOSUPRESORES","value_usd":"$404k","url":"https://ted.europa.eu/en/notice/-/detail/415914-2025"},{"date":"2025-06-17","buyer":"Gerencia del Área Sanitaria IV del Servicio de Salud del Principado de Asturias","country":"Spain","subject":"Suministro de Medicamentos exclusivos: Nivolumab y Ozanimod, para el Hospital Universitario Central de Asturias","value_usd":"$1.4M","url":"https://ted.europa.eu/en/notice/-/detail/502008-2025"},{"date":"2025-06-12","buyer":"HOSPITAL UNIVERSITARIO PUERTA DE HIERRO MAJADAHONDA","country":"Spain","subject":"SUMINISTRO DEL MEDICAMENTO ABECMA DISTRIBUIDOS EN EXCLUSIVIDAD POR EL LABORATORIO BRISTOL-MYERS SQUIBB,S.A.U.","value_usd":"$336k","url":"https://ted.europa.eu/en/notice/-/detail/380796-2025"},{"date":"2025-06-06","buyer":"Dirección General de Planificación Económica","country":"Spain","subject":"LOTE 16 - Contrato Basado en el Acuerdo Marco para la adquisición de medicamentos exclusivos de uso hospitalario con destino a las farmacias de los hospitales del Servicio Extremeño de Salud, siguiendo un procedimiento negociado sin publicidad.","value_usd":"$2.2M","url":"https://ted.europa.eu/en/notice/-/detail/365589-2025"},{"date":"2025-05-26","buyer":"Sansia Oy","country":"Finland","subject":"Lääkkeiden erillishankinnat Itä-Suomen yhteistyöalueelle","value_usd":"$1.8M","url":"https://ted.europa.eu/en/notice/-/detail/337735-2025"},{"date":"2025-05-19","buyer":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","country":"Italy","subject":"ARIA_2024_008.18 - Procedura aperta multilotto ai sensi dell’art. 71 del D.Lgs. n. 36/2023 per la fornitura di farmaci e servizi connessi","value_usd":"$25.3M","url":"https://ted.europa.eu/en/notice/-/detail/725809-2025"},{"date":"2025-05-06","buyer":"Gerencia de Atención Especializada de Salamanca","country":"Spain","subject":"Suministro del medicamento cuyo Principio Activo es NIVOLUMAB para el Complejo Asistencial Universitario de Salamanca.","value_usd":"$1.4M","url":"https://ted.europa.eu/en/notice/-/detail/360897-2025"}],"buyers":[{"name":"OSAKIDETZA - Servicio Vasco de Salud - Organización Central","detail":"Spain","value":"9"},{"name":"Servicio Andaluz de Salud. Servicios Centrales","detail":"Spain","value":"1"},{"name":"ARIA- Azienda Regionale per l'Innovazione e gli Acquisti S.p.A.","detail":"Italy","value":"3"},{"name":"Servicio Gallego de Salud","detail":"Spain","value":"3"},{"name":"Dirección General de Planificación Económica","detail":"Spain","value":"8"},{"name":"Servicio de Salud - Servicios Centrales","detail":"Spain","value":"2"},{"name":"Region Stockholm, Trafiknämnden","detail":"Sweden","value":"1"},{"name":"Servicio Cántabro de Salud","detail":"Spain","value":"3"},{"name":"SERVICIO MADRILEÑO DE SALUD","detail":"Spain","value":"1"},{"name":"Servicio Andaluz de Salud. Hospital Universitario de Jaén","detail":"Spain","value":"10"}],"bids":[{"date":"2026-11-10","buyer":"clinicpartner eG","country":"Germany","subject":"Lieferung von Opdivo","bid":"not stated","result":"not won"},{"date":"2026-11-10","buyer":"clinicpartner eG","country":"Germany","subject":"Lieferung von Yervoy","bid":"not stated","result":"not won"},{"date":"2025-12-22","buyer":"NHS England","country":"United Kingdom","subject":"NHS National Framework for Generics Housekeeping","bid":"$68.1M","result":"not won","url":"https://www.find-tender.service.gov.uk"},{"date":"","buyer":"Servicio Cántabro de Salud","country":"Spain","subject":"Suministro de medicamentos exclusivos del área onco/hematología","bid":"not stated","result":"not won","url":"https://ted.europa.eu/en/notice/-/detail/769835-2023"}],"as_of":"2026-11-21","cite":"Bristol Myers Squibb, Contracts. Alion, Nov 21, 2026. https://alion.io/company/bms/contracts","html_url":"https://alion.io/company/bms/contracts","json_url":"https://alion.io/company/bms/contracts.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-21T06:54:07Z"}}